Home/Filings/4/0000899243-21-005728
4//SEC Filing

MacDonald James J. 4

Accession 0000899243-21-005728

CIK 0001770121other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 6:40 PM ET

Size

12.6 KB

Accession

0000899243-21-005728

Insider Transaction Report

Form 4
Period: 2021-02-08
Transactions
  • Conversion

    Common Stock

    2021-02-08+93,750428,750 total
  • Conversion

    Common Stock

    2021-02-08+7,8127,812 total(indirect: By Trust)
  • Conversion

    Series A-1 Convertible Preferred Stock

    2021-02-0893,7500 total
    Common Stock (93,750 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2021-02-087,8120 total(indirect: By Trust)
    Common Stock (7,812 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    125,000
  • Common Stock

    (indirect: By Trust)
    125,000
Footnotes (2)
  • [F1]The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering.
  • [F2]The expiration date is not relevant to the conversion of these securities.

Issuer

Sana Biotechnology, Inc.

CIK 0001770121

Entity typeother

Related Parties

1
  • filerCIK 0001830054

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:40 PM ET
Size
12.6 KB